Consideration of cardiac event
recorder forecasts indicate that markets at $1.1 billion in 2016 will reach
$4.8 billion by 2023. Growth comes as
this technology is able to support the greater emphasis that is being put on
early diagnosis and prevention of disease by the medical community as a
whole. Heart disease has been the number
one killer of people, creating a need for more proactive and ongoing diagnosis
made possible by increased use of the remote units extending medical care from
the acute care setting to everyday modalities.
Digitalization of healthcare is
shifting value from devices per se to software and services. Physicians are looking for new ways to
proactively monitor and manage patient health.
The challenges of delivering patient cardiac care can only be met
through new, more integrated forms of care delivery across the health
continuum, with a shift away from a focus on acute care and late-stage
interventions to continuing care delivery that is appropriate to the
circumstance.
According to Susan Eustis,
principal author of the study, “In an increasingly connected world, the
convergence of vital signs technologies with cardiac event monitoring
technologies is able to facilitate healthy living. This fits very well with cardiac equipment vendor
core strengths in professional healthcare and in consumer health and
well-being.”
Disruptive technologies,
disruptive services offerings change cardiac event recorder markets, clinicians
are leveraging technology to save lives.
A cardiac event recorder is a
battery-powered portable miniature device.
Devices record heart's electrical activity (ECG) to detect presence of
symptoms. Event recorders can be a loop
memory monitor and a symptom event monitor with newer devices containing
internal analytics and the ability to notify a physician directly if an event
is detected. Cardiac event ambulatory
monitors can detect arrhythmias and get people to treatment faster before it is
too late. Units are useful in the fight
to correct congestive heart failure even after it has been initiated.
Shortness of breath is a common
symptom of cardiac disease. It is
frequently misdiagnosed as a respiratory symptom or ignored by patients and is
not even considered a symptom. Detection
of heart disease is supported with the newer cardiac event recorders. Early treatment is essential and the
technology is a vital aid in providing that treatment.
Other, newer technologies are
emerging. A vital signs patch supports
continuous, non-invasive monitoring of EKG, Heart Rate, respiration rate,
surface temperature, and arterial blood oxygen saturation. The device is an easy-to-use sensor worn on a
patient’s upper chest. It is intended to be used on adult patients in a
clinical environment.
The intended use group is adults
21 and above. Units are prescribed by a
physician or other qualified healthcare professional. Upon activation and connectivity to the
supporting system, the VSP provides automation and alerts of key vital signs
via continuous wireless monitoring.
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/cardiac-event-monitor-market/request-sample
Considerable interest and effort
has been put into patch-based devices aimed at improving convenience for the
patient and achieving better compliance.
MCT 1-lead patches have been developed.
Medtronic’s SEEQ device is such a unit.
BioTelemetry’s CardioNet MCOT and
Preventice BodyGuardian Heart have devices.
The newer patch based devices rely on MCT technology, iRhythm, a
US-based AECG specialist, is selling a somewhat differentiated patch, Zio
XT. Similar to Holter monitoring, the
device can record arrhythmias.
It can record 10 days of
continuous data, which is retrieved after completion of the monitoring, ie not
live transmission like in MCT.
Cardiologists would hardly be able to handle such large amounts of data,
therefore iRhythm has developed proprietary algorithms, which provide summary
reports.
Cardiac event monitor market
forecasts, event recorder device, MCT device, and implantable recorders are
charged for as services when the units are provided to patients in this
manner. Insurance reimbursement is many
times a more favorable way to collect money from a service.
The implantable segment of the
overall cardiac event recording market goes from 58% of the total to 80% of the
total. It implantable devices are far
more reliable and accurate than the electronic external devices.
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to
meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant
Insights, Inc
Contact Person: Michelle
Thoras
Email:
sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Comments
Post a Comment